|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��ͯ |
|
���� |
|
���� |
| ��������������� | |
|
� |
|
������ |
| PubMed | |
|
Article by |
|
Article by |
��ͯ���缰�����Ƶ��о���չ
�, ������
������ѧ������ɽҽԺƤ���� �Ϻ� 200040
��ͯ���������ٴ����ּ�����ѧ���ص���б��ڳ��˰���.�о���ʾ��ͯ���������Ե��Ա����,�ڶ��͵ı�����,�鷢���������Լ�����.���õ����Ʒ�����������Ƥ�ʼ��ء����ƺ���������,���꿨������������Ī˾�������ƶ�ͯ����Ҳȡ�ýϺõ���Ч.
[2] Handa S,Dogra S.Epidemiology of childhood vitiligo:a study of 625patients from north India.Pediatr Dermatol,2003,20:207-210.
[3] Kovacs SO.Vitiligo.J Am Acad Dermatol,1998,38:647-666.
[4] Prcic S,Duran V,Poljacki M.Vitiligo in childhood.Med Pregl,2002,55:475-480.
[5] Cho S,Kang HC,Hahm JH.Characteristics of vitiligo in Korean children.Pediatr Dermatol,2000,17:189-193.
[6] Rathinam SR,Vijayalakshmi P,Namperumalsamy P,et al.VogtKoyanagi-Harada syndrome in children.Ocul Immunol Inflamm,1998,6:155-161.
[7] Sharma VK,Kumar B,Dawn G.A clinical study of childhood alopecia areata in Chandigarh,India.Pediatr Dermatol,1996,13:372.
[8] Tan E,Tay YK,Giam YC.A clinical study of childhood alopecia areata in Singapore.Pediatr Dermatol,2002,19:298-301.
[9] Sawaya RA,Mourad FH,Najjar S,et al.Adrenoleukodystrophy associated with vitiligo and ulcerative colitis.Eur Neurol,1999,42:169.
[10] Peloro TM,Pride HB.Twenty-nail dystrophy and vitiligo:a rare association.J Am Acad Dermatol,1999,40:488-490.
[11] Papadopoulos L,Bor R,Legg C.Coping with the disfiguring effects of vitiligo:a preliminary investigation into the effects of cognitive-behavioural therapy.Br J Med Psychol,1999,72:385-396.
[12] Thompson AR,Kent G,Smith JA.Living with vitiligo:dealing with difference.Br J Health Psychol,2002,7:213-225.
[13] Njoo MD,Spuls PI,Bos JD,et al.Nonsurgical repigmentation therapies in vitiligo.Meta-analysis of the literature.Arch Dermatol,1998,134:1532-1540.
[14] Njoo MD,Westerhof W,Bos JD,et al.The development of guidelines for the treatment of vitiligo.Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico(IDI-IRCCS) and the Archives of Dermatology.Arch Dermatol,1999,135:1514-1521.
[15] Guilhou JJ.Calcipotriol.Ann Dermato1 Venereol,2001,128:229.
[16] Ermis O,Alpsoy E,Cetin L,Is the effic acy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol?A placebo-controlled double-blind study.Br J Dermatol,2001,145:472-475.
[17] Parsad D,Saini R,Nagpal R.Calcipotriol in vitiligo:a preliminary study.Pediatr Dermatol,1999,16:317-320.
[18] Plettenberg H,Assmann T,Ruzicka T.Childhood vitiligo and tacrolimus:immunomodulating treatment for an autoimmune disease.Arch Dermatol,2003,139:651-654.
[19] Lepe V,Moncada B,Castanedo-Cazares JP,et al.A double-blind randomized trial of 0.1% tacro1imus vs 0.05% clobetasol for the treatment of childhood vitiligo.Arch Dermatol,2003,139:581-585.
[20] Njoo MD,Bos JD,Westerhof W.Treatment of generalized vitiligo in children with narrow-band(TL-01) UVB radiation therapy.J Am Acad Dermatol,2000,42:245-253.
[21] Baltas E,Csoma Z,Ignacz F,et al.Treatment of vitiligo with the 308nm xenon chloride excimer laser.Arch Dermatol,2002,138:1619-1620.
[22] Olsson MJ,Juhlin L.Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes,ultrathin epidermal sheets and basal cell layer suspension.Br J Dermatol,2002,147:893-904.
[23] Gupta S,Kumar B.Epidermal grafting for vitiligo in adolescents.Pediatr Dermatol,2002,19:159-162.
[24] Mulekar SV.Melanocyte-keratinocyte cell transplantation for stable vitiligo.Int J Dermatol,2003,42:132-136.